Krilogy Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.68M Buy
597,562
+143,661
+32% +$2.01M 0.25% 71
2025
Q4
$6.43M Buy
453,901
+91,213
+25% +$1.37M 0.22% 76
2025
Q3
$5.4M Buy
+362,688
New +$5.97M 0.2% 78

Other funds holding BTAL

Krilogy Financial's BTAL Position: Q1 2026 in Review

Krilogy Financial increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 32% in Q1 2026, buying an estimated $2.01M and bringing the position to 597,562 shares worth $7.68M. The position accounts for 0.25% of the portfolio, ranked #71.

Krilogy Financial first reported a position in BTAL in Q3 2025 and has held it in 3 quarters since. 87 funds tracked by Wall St. Rank hold BTAL as of Q1 2026.

  • Krilogy Financial held 597,562 shares of AGF US Market Neutral Anti-Beta Fund worth $7.68M as of Q1 2026.
  • Krilogy Financial bought 143,661 AGF US Market Neutral Anti-Beta Fund shares in Q1 2026, an estimated $2.01M.
  • AGF US Market Neutral Anti-Beta Fund made up 0.25% of Krilogy Financial's portfolio in Q1 2026, its #71 holding.
  • Krilogy Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2025 and has held it in 3 quarters since.
  • 87 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.